ArticleJournal of thrombosis and haemostasis : JTH2022

Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.

Pancras C Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.